The products were marketed without FDA approval.
In addition, the product claims on the firm's website make the products unapproved new drugs, and the labeling fails to bear adequate directions for use.
There are no reports of adverse effects.
The following items, sold throughout the U.S., and to one consignee in New Zealand, are being recalled:
| Product Name | Strength(mg) | Multiple Dose Vial Size | Lot | Expiration |
|---|---|---|---|---|
| Cannabidiol(CBD) Complex | 40 | 10 mL | 2H071219P | 07/12/2021 |
| 500 | 10 mL | 10102019P | 10/10/2021 | |
| Curcumin Complex | 40 | 10 mL | 2H071219CCD | 07/12/2021 |
| 500 | 10 mL | 0712019CCD | 07/12/2021 | |
| Cannabidiol + Curcumin | 500 | 10 mL | 10102019PC | 10/10/2021 |
What to do
Customers who purchased the recalled products should stop using and return them to place of purchase.
Consumers with questions may contact Biota Biosciences at (866) 996-2293 Monday -- Friday 8:00 am -- 4:00 pm (PST), or by e-mail at hq@biotacbd.com.
Share your comments